Multicomponent Thiolactone-Based Ionizable Lipid Screening Platform for an Efficient and Tunable mRNA Delivery to the Lungs

Alvaro Pena,Juan Heredero,Beatriz Blandin,Elena Mata,Diego De Miguel,Alfonso Toro,Teresa Alejo,Diego Casabona,Alexandre Lopez,Ana Gallego-Lleyda,Esther Perez-Herran,Juan Martinez-Olivan,Javier Gimenez-Warren

DOI: https://doi.org/10.1101/2024.10.09.617396

2024-10-10

Abstract:Ionizable lipids are an essential component of lipid nanoparticles (LNPs) for an efficient mRNA delivery. However, optimizing their chemical structures for high protein expression, efficient endosomal escape, and selective organ targeting remains challenging due to complex structure-activity relationships and multistep synthesis. In this study, we introduce a rapid, high-throughput platform for screening ionizable lipids using a two-step, scalable synthesis involving a one-pot 3-component click-like reaction. This method, herein known as the STAAR approach, standing for Sequential Thiolactone Amine Acrylate Reaction, allowed for the combinatorial synthesis and in vivo screening of 91 novel lipids, followed by a structure-activity study. This led to the development of CP-LC-0729, an ionizable lipid that significantly surpasses the benchmark in protein expression while showing no in vivo toxicity. Additionally, the STAAR lipid platform was further validated by incorporating a one-step strategy to yield a permanently cationic lipid which was tested following a fifth-lipid formulation strategy. The in vivo results showed a highly selective lung delivery with a 32-fold increase in protein expression, outperforming current endogenous targeting strategies. All these findings underscore the potential of lipid CP-LC-0729 and the STAAR lipid platform in advancing the efficiency and specificity of mRNA delivery systems, while also advancing the development of new ionizable lipids.

Biochemistry

What problem does this paper attempt to address?

### What problems does this paper attempt to solve?

This paper aims to solve the following key problems:

1. **Optimizing the chemical structure of ionizable lipids**:
- Ionizable lipids are key components in lipid nanoparticles (LNP) for efficient mRNA delivery. However, currently, there are still challenges in how to design their chemical structures to achieve efficient protein expression, effective endosomal escape, and selective organ targeting. Specifically, the complex structure - activity relationships and multi - step synthesis processes make it difficult to optimize these lipids.

2. **Developing a rapid and efficient screening platform**:
- The paper introduces a rapid high - throughput screening platform named STAAR (Sequential Thiolactone Amine Acrylate Reaction). This platform enables the combinatorial synthesis of ionizable lipids through a two - step one - pot reaction and can perform in vivo screening of 91 novel lipids. This method not only simplifies the synthesis process but also improves the screening efficiency.

3. **Enhancing the selective delivery of mRNA in the lungs**:
- Through the STAAR platform, a new ionizable lipid CP - LC - 0729 has been developed, which significantly outperforms the existing benchmarks in protein expression and has no in vivo toxicity. In addition, the study also verified a one - step strategy for a permanent cationic lipid, further enhancing the selective delivery in the lungs with a 32 - fold increase in protein expression.

4. **Understanding the structure - activity relationships**:
- Through systematic structure optimization and screening, the study reveals the influence of different structural fragments (such as polar head groups, linking chains, and hydrophobic tail chains) on lipid performance. In particular, it is found that the length and branching structure of the hydrophobic tail chain have a significant impact on protein expression, emphasizing the importance of minor structural changes.

5. **Improving the efficiency and specificity of the mRNA delivery system**:
- Overall, the development of the STAAR platform and the CP - LC - 0729 lipid provides new possibilities for improving the efficiency and specificity of the mRNA delivery system, especially showing great potential in targeted delivery to extra - hepatic tissues (such as the lungs).

By solving these problems, this study lays the foundation for developing more efficient and safer mRNA delivery systems, especially having important application prospects in cancer treatment and gene therapy for other diseases.